Publications by authors named "Miguel Cervero"

Claim this Profile
D
Differences in the peripheral blood immune landscape between early-onset and late-onset colorectal cancer.
Clara Sánchez-Menéndez, Jaime Rodríguez-Pérez, Daniel Fuertes, Valentina Leguizamon, María González-Sanmartín, Miguel Cervero

Front Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune dysregulation and endothelial dysfunction associate with a pro-thrombotic profile in Long COVID.
Alicia Simón-Rueda, Clara Sánchez-Menéndez, Guiomar Casado, Daniel Fuertes, María Aránzazu Murciano-Antón, Miguel Cervero

Front Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in HIV-1 Reservoir Dynamics After Mpox Infection.
Guiomar Casado-Fernández, Olivia de la Calle-Jiménez, Inés Armenteros, Luis Lemus Aguilar, Daniel Fuertes, Miguel Cervero

J Med Virol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective study for the early detection of lung carcinoma in patients with HIV infection (GESIDA study 8815).
M Eulalia Valencia, Tatiana Pirogova, Delia Romera, Marta Montero, María Tasías, Miguel Cervero

Enferm Infecc Microbiol Clin (Engl Ed)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib interferes with HIV-1 proviral integration and the inflammatory potential of monocyte-derived macrophages from people with HIV.
Sara Rodríguez-Mora, Clara Sánchez-Menéndez, Guiomar Bautista-Carrascosa, Elena Mateos, Lucia Moreno-Serna, Miguel Cervero

Biochem Pharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to: "Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D" [Biomed. Pharmacother. 150 (2022) 1-11].
Montserrat Torres, Guiomar Casado, Lorena Vigón, Sara Rodríguez-Mora, Elena Mateos, Miguel Cervero

Biomed Pharmacother· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different polarization and functionality of CD4+ T helper subsets in people with post-COVID condition.
Clara Sánchez-Menéndez, Olivia de la Calle-Jiménez, Elena Mateos, Lorena Vigón, Daniel Fuertes, Miguel Cervero

Front Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained antiviral response against HIV-1 infection in peripheral blood mononuclear cells from people with chronic myeloid leukemia treated with ponatinib.
Mario Manzanares, Fernando Ramos-Martín, Sara Rodríguez-Mora, Guiomar Casado-Fernández, Clara Sánchez-Menéndez, Miguel Cervero

Front Pharmacol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virus.
Guiomar Casado-Fernández, Juan Cantón, Laura Nasarre, Fernando Ramos-Martín, Mario Manzanares, Miguel Cervero

Front Immunol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of Sexualized Drug Use among Gay, Bisexual, and Other Men Who Have Sex with Men Living with HIV: Insights from a Comprehensive Study-The U-SEX-2 GESIDA 9416 Study.
Pablo Ryan, Helen Dolengevich-Segal, Luis Ramos-Ruperto, Alfonso Cabello, Matilde Sanchez-Conde, Miguel Cervero

J Clin Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV medical care interruption among people living with HIV in Spain, 2004-2020.
Rebeca Izquierdo, Marta Rava, Estela Moreno-García, José Ramón Blanco, Víctor Asensi, Miguel Cervero

AIDS· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort.
Hortensia Álvarez, Marta Rava, Cristina Martínez, Joaquín Portilla, Joaquim Peraire, Miguel Cervero

HIV Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amikacin pharmacokinetics in elderly patients with severe infections.
Susanna E Medellín-Garibay, Melissa Romano-Aguilar, Alejandro Parada, David Suárez, Silvia Romano-Moreno, Miguel Cervero

Eur J Pharm Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beneficial Effect of Short-Term Supplementation of High Dose of Vitamin D in Hospitalized Patients With COVID-19: A Multicenter, Single-Blinded, Prospective Randomized Pilot Clinical Trial.
Miguel Cervero, Daniel López-Wolf, Guiomar Casado, Maria Novella-Mena, Pablo Ryan-Murua

Front Pharmacol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D.
Montserrat Torres, Guiomar Casado, Lorena Vigón, Sara Rodríguez-Mora, Elena Mateos, Miguel Cervero

Biomed Pharmacother· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study.
Jesús Troya, Carlos Dueñas, Idoia Irazola, Ignacio de Los Santos, Sara de la Fuente, Miguel Cervero

Medicine (Baltimore)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late HIV diagnosis among immigrants in Spain vs. native-born Spaniards, 2010-15.
Megi Gogishvili, Terry T-K Huang, Sergio A Costa, Karen Florez, Pedro Mateu-Gelabert, Miguel Cervero

Eur J Public Health· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy.
Lorena Vigón, Paula Martínez-Román, Sara Rodríguez-Mora, Montserrat Torres, María C Puertas, Miguel Cervero

Biochem Pharmacol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired Antibody-Dependent Cellular Cytotoxicity in a Spanish Cohort of Patients With COVID-19 Admitted to the ICU.
Lorena Vigón, Javier García-Pérez, Sara Rodríguez-Mora, Montserrat Torres, Elena Mateos, Miguel Cervero

Front Immunol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired Cytotoxic Response in PBMCs From Patients With COVID-19 Admitted to the ICU: Biomarkers to Predict Disease Severity.
Lorena Vigón, Daniel Fuertes, Javier García-Pérez, Montserrat Torres, Sara Rodríguez-Mora, Miguel Cervero

Front Immunol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mortality in Perinatally HIV-infected Adolescents After Transition to Adult Care in Spain.
Arantxa Berzosa Sánchez, Santiago Jiménez De Ory, M Antoinette Frick, Ana Isabel Menasalvas Ruiz, José Antonio Couceiro, Miguel Cervero

Pediatr Infect Dis J· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study.
Jesús Troya, Rocio Montejano, Pablo Ryan, Cristina Gómez, Mariano Matarranz, Miguel Cervero

PLoS One· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of and risk factors for low bone mineral density in Spanish treated HIV-infected patients.
Miguel Cervero, Rafael Torres, Jose Luís Agud, Victoria Alcázar, Juan José Jusdado

PLoS One· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial.
Federico Pulido, Esteban Ribera, María Lagarde, Ignacio Pérez-Valero, Rosario Palacios, Miguel Cervero

Clin Infect Dis· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Predictive factors of clinically significant drug-drug interactions among regimens based on protease inhibitors, non-nucleoside reverse transcriptase inhibitors and raltegravir].
Miguel Cervero, Rafael Torres, Juan José Jusdado, Susana Pastor, Jose Luis Agud

Med Clin (Barc)· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis